Why AzurRx Stock Is Trading Higher After MS1819 Combo Therapy Data?
August 18, 2021 at 07:34 AM EDT
AzurRx BioPharma Inc(NASDAQ: AZRX) hasannounced topline resultsfrom its Phase 2 Combination Trial evaluating MS1819 ...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.